Sionna Therapeutics, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Sionna Therapeutics, Inc. (SION) holds an ST Score of 37.9 out of 100 (C), with its strongest factor being Financial Strength (A-) and its weakest Sentiment (F). Analysts rate SION Hold across 8 ratings with a $27.40 average price target (+3.6% vs the current $5.96).
- Strongest
- Financial StrengthA-
- Weakest
- SentimentF
All factor grades
- Financial StrengthA-
- ForecastB+
- ProfitabilityB
- ValuationB-
- MomentumD+
- GrowthD-
- SentimentF
- Piotroski0/9
Contact
SION stock: frequently asked questions
What is SION's ST Score?
Sionna Therapeutics, Inc. (SION) has an ST Score of 37.9 out of 100, an overall grade of C. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SION a buy, sell, or hold?
Wall Street's consensus rating on SION is Hold based on 8 analyst ratings. Our own ST Score grades it C (37.9/100). This is data, not investment advice — always do your own research.
What is SION's valuation grade?
Sionna Therapeutics, Inc. (SION) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SION's growth grade?
Sionna Therapeutics, Inc. (SION) earns a growth grade of D-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SION's profitability grade?
Sionna Therapeutics, Inc. (SION) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SION's financial strength grade?
Sionna Therapeutics, Inc. (SION) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SION?
The average analyst price target for Sionna Therapeutics, Inc. (SION) is $27.40 from 8 analysts, which is +3.6% versus the recent price of $5.96.
What is SION's Piotroski score?
Sionna Therapeutics, Inc. (SION) has a Piotroski F-Score of 0 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.